Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers ; volume:22 ; number:1 ; day:13 ; month:8 ; year:2022 ; pages:1-27 ; date:12.2022
Cancer cell international ; 22, Heft 1 (13.8.2022), 1-27, 12.2022
- Urheber
-
Ghafouri-Fard, Soudeh
Noie Alamdari, Ali
Noee Alamdari, Yashar
Abak, Atefe
Hussen, Bashdar Mahmud
Taheri, Mohammad
Jamali, Elena
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-022-02676-x
- URN
-
urn:nbn:de:101:1-2022102911112151561306
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ghafouri-Fard, Soudeh
- Noie Alamdari, Ali
- Noee Alamdari, Yashar
- Abak, Atefe
- Hussen, Bashdar Mahmud
- Taheri, Mohammad
- Jamali, Elena
- SpringerLink (Online service)
Ähnliche Objekte (12)
FGF6 inhibits oral squamous cell carcinoma progression by regulating PI3K/AKT and MAPK pathways
Roxarsone induces angiogenesis via PI3K/Akt signaling
SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
Author Correction: FGF6 inhibits oral squamous cell carcinoma progression by regulating PI3K/AKT and MAPK pathways
Mechanism of apoptosis in oral squamous cell carcinoma promoted by cardamonin through PI3K/AKT signaling pathway
PI3K/AKT signaling drives titanium-induced angiogenic stimulus
Midkine promotes glioblastoma progression via PI3K-Akt signaling
Interplay between PI3K/AKT pathway and heart disorders
Interplay between PI3K/AKT pathway and heart disorders
HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT
FGF6 inhibits oral squamous cell carcinoma progression by regulating PI3K/AKT and MAPK pathways
Roxarsone induces angiogenesis via PI3K/Akt signaling
SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
Author Correction: FGF6 inhibits oral squamous cell carcinoma progression by regulating PI3K/AKT and MAPK pathways
Mechanism of apoptosis in oral squamous cell carcinoma promoted by cardamonin through PI3K/AKT signaling pathway
PI3K/AKT signaling drives titanium-induced angiogenic stimulus
Midkine promotes glioblastoma progression via PI3K-Akt signaling
Interplay between PI3K/AKT pathway and heart disorders
Interplay between PI3K/AKT pathway and heart disorders
HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes
Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT
FGF6 inhibits oral squamous cell carcinoma progression by regulating PI3K/AKT and MAPK pathways
Roxarsone induces angiogenesis via PI3K/Akt signaling
SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
Author Correction: FGF6 inhibits oral squamous cell carcinoma progression by regulating PI3K/AKT and MAPK pathways
Mechanism of apoptosis in oral squamous cell carcinoma promoted by cardamonin through PI3K/AKT signaling pathway
PI3K/AKT signaling drives titanium-induced angiogenic stimulus
Midkine promotes glioblastoma progression via PI3K-Akt signaling
Interplay between PI3K/AKT pathway and heart disorders
Interplay between PI3K/AKT pathway and heart disorders
HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway
PI3K-Akt and Raf-MEK-ERK signalling in adipocytes